Trial Profile

A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate [AZD-6244] in the Presence and Absence of Food in Patients With Advanced Solid Malignancies.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Oct 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Selumetinib (Primary)
Indications Solid tumours
Focus Pharmacokinetics
Sponsors AstraZeneca

Most Recent Events

01 Dec 2011 Results published in Cancer Chemotherapy and Pharmacology.
23 Nov 2010 New source identified and integrated (United Kingdom Clinical Research Network).
12 May 2010 Actual patient number (30) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com